We studied a 42-year-old man belonging to a large family with several affected members including his two sons. He had received mexiletine, 200 mg three times daily. Clinical symptoms were measured by the Muscular Disability Rating Scale, before and after 1-month treatment with PH. Electrophysiologic investigations were also performed before and after treatment. After PH treatment, the patient reported complete relief from symptoms, without adverse effects.

Efficacy of propafenone in paramyotonia congenita

TONINI, MARCELLO;RAVAGLIA, SABRINA MARIA;MOGLIA, ARRIGO
2007-01-01

Abstract

We studied a 42-year-old man belonging to a large family with several affected members including his two sons. He had received mexiletine, 200 mg three times daily. Clinical symptoms were measured by the Muscular Disability Rating Scale, before and after 1-month treatment with PH. Electrophysiologic investigations were also performed before and after treatment. After PH treatment, the patient reported complete relief from symptoms, without adverse effects.
2007
The Neurology category covers resources concerned with the central and peripheral nervous system including the brain, spinal cord, nerves, and fluids. Coverage includes general and clinical neurology including neurosurgery, neuropsychiatry, neuropsychology, neurophysiology, neuroradiology, neuropediatrics, neuropathology, and neurobiology. Resources on cerebrovascular diseases, movement and spinal disorders, pain, dementia, headache, aphasiology, brain injury, paraplegia, stroke, and acupuncture are also included.
Sì, ma tipo non specificato
Inglese
Internazionale
STAMPA
68
13
1080
1081
PARAMYOTONIA CONGENITA; MUSCLE DISEASE; PROPAPHENONE
7
info:eu-repo/semantics/article
262
Alfonsi, E; Merlo, Im; Tonini, Marcello; Ravaglia, SABRINA MARIA; Brugnoni, R; Gozzini, A; Moglia, Arrigo
1 Contributo su Rivista::1.1 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/143628
Citazioni
  • ???jsp.display-item.citation.pmc??? 14
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact